Arcellx (ACLX) Assets Average (2022 - 2025)
Arcellx (ACLX) recorded quarterly Assets Average of $630.0 million in Q4 2025, down 1.18% quarter-over-quarter from $637.5 million in Q3 2025, and down 14.65% on a YoY basis from $738.1 million in Q4 2024.
Arcellx (ACLX) Assets Average (2022 - 2025) Analysis & Trends
Arcellx's Assets Average history runs 4 years deep, the most recent figure standing at $630.0 million for Q4 2025.
- In Q4 2025, Assets Average fell 14.65% year-over-year to $630.0 million; the TTM figure through Dec 2025 stood at $630.0 million (down 14.65% YoY), while the FY2025 annual figure was $657.7 million, down 14.39% from the prior year.
- Assets Average was $630.0 million for Q4 2025 at Arcellx, down from $637.5 million in the prior quarter.
- In the past five years, Assets Average ranged from a high of $802.4 million in Q1 2024 to a low of $187.9 million in Q1 2022.
- Historically, Assets Average has averaged $577.4 million across 4 years, with a median of $631.8 million in 2025.
- The sharpest annual moves came in 2023 and 2025: Assets Average soared 149.29% in 2023, then retreated 16.3% in 2025.
- A 4-year view of Assets Average shows it stood at $325.6 million in 2022, then surged by 121.05% to $719.7 million in 2023, then advanced by 2.56% to $738.1 million in 2024, then declined by 14.65% to $630.0 million in 2025.
- The last three Assets Average figures came in at $630.0 million (Q4 2025), $637.5 million (Q3 2025), and $633.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - | 629.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 629.95 Mn |
| Sep 30, 2025 | 637.50 Mn |
| Jun 30, 2025 | 633.58 Mn |
| Mar 31, 2025 | 679.70 Mn |
| Dec 31, 2024 | 738.12 Mn |
| Sep 30, 2024 | 749.61 Mn |
| Jun 30, 2024 | 757.00 Mn |
| Mar 31, 2024 | 802.41 Mn |
| Dec 31, 2023 | 719.68 Mn |
| Sep 30, 2023 | 618.87 Mn |
| Jun 30, 2023 | 623.24 Mn |
| Mar 31, 2023 | 468.38 Mn |
| Dec 31, 2022 | 325.57 Mn |
| Sep 30, 2022 | 356.00 Mn |
| Jun 30, 2022 | 310.82 Mn |
| Mar 31, 2022 | 187.88 Mn |